News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Slideshows|December 5, 2017

13 Contributing Factors to Treatment-Resistant Bipolar Disorder

Author(s)Charles B. Schaffer, MD, Linda C. Schaffer, MD, Jeanne Howe, MA

Several non-biological factors often contribute significantly to treatment resistance.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

February theme

Presenting Our February 2026 Theme: Bipolar Disorder

February 2nd 2026

bipolar

Phase 2 Trial Initiated: LB-102 for Bipolar Depression

January 26th 2026

brain

sNDA Submission: Igalmi for Acute Treatment of Agitation Associated With Bipolar Disorders or Schizophrenia in Outpatient Setting

January 20th 2026

New Year’s Resolutions and Bipolar Disorder: Insights from Jo Hughes, DSMc, PA-C, CAQ-PSYCH

ByJo A. Hughes, DMSc, PA-C, CAQ-PSY,Jessica Walters

January 1st 2026

Programs for ST-905 and ST-905 for Schizophrenia and Depression Launched by Syremis Therapeutics

ByJessica Walters

December 24th 2025

Latest CME

Optimizing Care for Patients With Tardive Dyskinesia

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Trending on Psychiatric Times

Depression and Long COVID Outcomes in Women: New Data Analysis

Investigational Psilocybin for PTSD and Ongoing Trials

Patterns of Propensity: A Review of Heinrichs’ How Psychiatrists Make Decisions

Extension of Expanded Access Program for Zervimesine to Treat Dementia With Lewy Bodies

Why Global Integration Is Essential for the Future of DSM